PAMELA KENNEDY: Open Payments
NPI 1497037493 · PORTSMOUTH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$796 in 24 payments from 9 companies in 2025. Trend: 2023 $1,382 · 2024 $1,554 · 2025 $796
Food & beverage: $796
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $307 |
| Lilly USA, LLC | 3 | $234 |
| Novo Nordisk Inc | 4 | $142 |
| PFIZER INC. | 2 | $34 |
| Biogen, Inc. | 1 | $24 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
| Axsome Therapeutics, Inc. | 1 | $14 |
| Organon LLC | 1 | $8 |
Products named: QULIPTA, MOUNJARO, Ozempic, ZEPBOUND, BOTOX, Wegovy, ZURZUVAE, NURTEC ODT.
Industry payments across VA — which companies pay providers there.
